VAV guanine nucleotide exchange factor 1 (VAV1) is reported to be overexpressed in clinical pancreatic carcinoma cells, leading to activation of Rac1 signaling, resulting in decreased survival in pancreatic cancer patients [12, 13]. This evidence concerns the gene RAC1 and pancreatic neoplasm.